SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,000 | -4.3% | 300 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $23,000 | -14.8% | 300 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $27,000 | -3.6% | 300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $28,000 | +21.7% | 300 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $23,000 | +4.5% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $22,000 | -56.9% | 300 | 0.0% | 0.01% | -58.8% |
| Q4 2020 | $51,000 | +21.4% | 300 | 0.0% | 0.02% | +6.2% |
| Q3 2020 | $42,000 | -12.5% | 300 | 0.0% | 0.02% | -20.0% |
| Q2 2020 | $48,000 | +65.5% | 300 | 0.0% | 0.02% | +33.3% |
| Q1 2020 | $29,000 | -23.7% | 300 | 0.0% | 0.02% | -11.8% |
| Q4 2019 | $38,000 | +65.2% | 300 | 0.0% | 0.02% | +41.7% |
| Q3 2019 | $23,000 | -50.0% | 300 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $46,000 | -23.3% | 300 | -40.0% | 0.02% | -22.6% |
| Q1 2019 | $60,000 | +11.1% | 500 | 0.0% | 0.03% | -3.1% |
| Q4 2018 | $54,000 | -33.3% | 500 | 0.0% | 0.03% | -25.6% |
| Q3 2018 | $81,000 | – | 500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |